Get the Stockscreener App
33.63
0.41%
-0.14
Bright Minds Biosciences Inc stock is traded at $33.63, with a volume of 43,075.
It is down -0.41% in the last 24 hours and up +26.52% over the past month.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
See More
Previous Close:
$33.77
Open:
$33.32
24h Volume:
43,075
Relative Volume:
1.10
Market Cap:
$236.89M
Revenue:
-
Net Income/Loss:
$-4.98M
P/E Ratio:
-25.52
EPS:
-1.3177
Net Cash Flow:
$-3.85M
1W Performance:
-5.15%
1M Performance:
+26.52%
6M Performance:
-1.09%
1Y Performance:
+2,824%
1-Day Range:
$31.98
$34.37
1-Week Range:
$31.80
$36.99
52-Week Range:
$0.94
$79.02
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Name
Bright Minds Biosciences Inc
Sector
Industry
Phone
-
Address
-
Compare DRUG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRUG
Bright Minds Biosciences Inc
|
33.63 | 239.20M | 0 | -4.98M | -3.85M | -1.3177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-13-25 | Initiated | TD Cowen | Buy |
| May-07-25 | Initiated | Chardan Capital Markets | Buy |
| Jan-23-25 | Initiated | Piper Sandler | Overweight |
| Jan-10-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-10-25 | Initiated | H.C. Wainwright | Buy |
| Nov-26-24 | Initiated | Robert W. Baird | Outperform |
View All
Bright Minds Biosciences Inc Stock (DRUG) Latest News
What are Bright Minds Biosciences Inc. company’s key revenue driversReal Time Alerts For Fast Growth - jammulinksnews.com
How many analysts rate Bright Minds Biosciences Inc. as a “Buy”Smart Portfolio Strategy With High Returns - jammulinksnews.com
What makes Bright Minds Biosciences Inc. stock price move sharplyFree Stock Forecasts That Work - jammulinksnews.com
Chart based exit strategy for Bright Minds Biosciences Inc.Daily Profit Watch With Forecast Confidence - Newser
Bright Minds Biosciences Inc. stock outlook for YEARFree Fundamental Growth Stock Analysis - Newser
Technical signs of recovery in Bright Minds Biosciences Inc.Free Triple Digit Growth Focused Trade Plan - Newser
Can Bright Minds Biosciences Inc. stock recover from recent declineFree Stock Portfolio Allocation Guidance - Newser
How to track smart money flows in Bright Minds Biosciences Inc.Algorithmic Forecast for Swing Trading Picks - Newser
Bright Minds Biosciences Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Buy Low Sell High Stock Watch - Newser
Sentiment analysis tools applied to Bright Minds Biosciences Inc.Smart Forecast Signals from AI Models - Newser
Earnings visualization tools for Bright Minds Biosciences Inc.Trading Opportunities Forecast by AI Insight - Newser
Should I hold or sell Bright Minds Biosciences Inc. stock in 2025Expert Picks Tips With High Returns - jammulinksnews.com
What is Bright Minds Biosciences Inc. company’s growth strategyExpert Picks Insights For Fast Growth - jammulinksnews.com
New Product Launches: Will They Boost Bright Minds Biosciences Inc. Stock in 2025Controlled Entry Strategy With Safety Analytics - Newser
Published on: 2025-07-30 02:55:13 - metal.it
Short Interest Drops in Bright Minds Biosciences Inc. After RallyROI Driven Equity Selection With Safety Emphasized - beatles.ru
Bright Minds Biosciences Inc. Sees Relief Buying After Extended DropPattern Alert With ROI Driven Strategy Shared - metal.it
Published on: 2025-07-29 04:17:58 - Newser
Does Bright Minds Biosciences Inc. stock pay reliable dividendsFree Short Term Buy List With Stop Protection - Newser
What catalysts could drive Bright Minds Biosciences Inc. stock higher in 2025Earnings Report Opportunities To Watch Now - jammulinksnews.com
What are analysts’ price targets for Bright Minds Biosciences Inc. in the next 12 monthsAchieve rapid financial growth with expert help - jammulinksnews.com
What institutional investors are buying Bright Minds Biosciences Inc. stockUnlock expert insights for smarter investing - jammulinksnews.com
What is the risk reward ratio of investing in Bright Minds Biosciences Inc. stockDiscover high-growth stocks for your portfolio - jammulinksnews.com
How strong is Bright Minds Biosciences Inc. company’s balance sheetGet daily expert analysis for smarter investing - jammulinksnews.com
Why is Bright Minds Biosciences Inc. stock attracting strong analyst attentionGet professional advice for market timing - jammulinksnews.com
What are the latest earnings results for Bright Minds Biosciences Inc.Invest in stocks with long-term growth potential - jammulinksnews.com
When is Bright Minds Biosciences Inc. stock expected to show significant growthUnlock expert stock analysis and alerts - jammulinksnews.com
Bright Minds Biosciences Inc. Earnings Report Breakdown: What Investors Should KnowSafe Entry High Exit Alerts - Newser
Will Bright Minds Biosciences Inc. Stock Benefit from AI and Green Energy TrendsInsider Strategy Insight - Newser
What analysts say about Bright Minds Biosciences Inc. stockFree Wealth Management Insights - PrintWeekIndia
Is Bright Minds Biosciences Inc. stock overhyped or has real potentialFree High-Return Strategy Alerts - jammulinksnews.com
Bright Minds Biosciences Inc. Stock Analysis and ForecastGame-changing capital returns - Autocar Professional
Uncover the Best-Performing Canadian Biotech Stocks of 2025 - Investing News Network
Brokerages Set Bright Minds Biosciences Inc. (NASDAQ:DRUG) Price Target at $83.25 - Defense World
What drives Bright Minds Biosciences Inc. stock priceFree Stock Market Beginners Guide - Autocar Professional
Is Bright Minds Biosciences Inc. a good long term investmentFree Investment Portfolio Suggestions - Autocar Professional
Bright Minds Biosciences Inc Stock (DRUG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bright Minds Biosciences Inc Stock (DRUG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 10% Owner |
Oct 15 '24 |
Buy |
5.53 |
372,591 |
2,061,574 |
825,000 |
| Cormorant Asset Management, LP | 10% Owner |
Oct 16 '24 |
Buy |
23.46 |
50,000 |
1,172,813 |
875,000 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):